Segall Bryant & Hamill’s Core Laboratories CLB Stock Holding History

Segall Bryant & Hamill’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,311	Closed	-$298K	–	820
2019 Q1	$298K	Sell	4,311 -13,803	-76%	-$925K	﹤0.01%	743
2018 Q4	$1.08M	Sell	18,114 -40,135	-69%	-$3.46M	0.02%	508
2018 Q3	$6.75M	Sell	58,249 -5,806	-9%	-$655K	0.1%	250
2018 Q2	$8.08M	Buy	+64,055	New	+$7.8M	0.12%	217
2017 Q2	–	Sell	-3,700	Closed	-$427K	–	559
2017 Q1	$427K	Buy	3,700 +250	+7%	+$29.1K	0.01%	430
2016 Q4	$414K	Hold	3,450	–	–	0.01%	427
2016 Q3	$388K	Sell	3,450 -1,800	-34%	-$207K	0.01%	438
2016 Q2	$650K	Hold	5,250	–	–	0.02%	389
2016 Q1	$590K	Sell	5,250 -250	-5%	-$26K	0.01%	394
2015 Q4	$598K	Hold	5,500	–	–	0.01%	386
2015 Q3	$549K	Hold	5,500	–	–	0.01%	408
2015 Q2	$627K	Hold	5,500	–	–	0.01%	395
2015 Q1	$575K	Hold	5,500	–	–	0.01%	408
2014 Q4	$662K	Hold	5,500	–	–	0.01%	391
2014 Q3	$805K	Hold	5,500	–	–	0.02%	373
2014 Q2	$919K	Hold	5,500	–	–	0.02%	334
2014 Q1	$1.09M	Hold	5,500	–	–	0.03%	319
2013 Q4	$1.05M	Hold	5,500	–	–	0.02%	331
2013 Q3	$931K	Hold	5,500	–	–	0.02%	334
2013 Q2	$834K	Buy	+5,500	New	+$779K	0.02%	317

Other funds holding CLB

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Segall Bryant & Hamill's CLB Position: Q2 2019 in Review

Segall Bryant & Hamill sold out of Core Laboratories (CLB) in Q2 2019, closing a stake of 4,311 shares — an estimated $298K sold.

Segall Bryant & Hamill first reported a position in CLB in Q2 2013 and held it in 20 quarters. The position peaked at $8.08M in Q2 2018. 304 funds tracked by Wall St. Rank hold CLB as of Q2 2019.

Segall Bryant & Hamill reported no remaining Core Laboratories position as of Q2 2019 after selling out during the quarter.
Segall Bryant & Hamill sold 4,311 Core Laboratories shares in Q2 2019, an estimated $298K.
Segall Bryant & Hamill first reported a position in Core Laboratories in Q2 2013 and held it in 20 quarters.
Segall Bryant & Hamill's Core Laboratories position peaked at $8.08M in Q2 2018.
304 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2019.

Based on Segall Bryant & Hamill's 13F filing for Q2 2019, filed 14 Aug 2019.